Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Childhood Oligodendroglioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00004113
What this trial is testing

Temozolomide in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT02388659
What this trial is testing

Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas

Who this might be right for
Malignant GliomasOligodendrogliomasAstrocytomas
University of Texas Southwestern Medical Center 142
Early research (Phase 1)Looking for participantsNCT04541082
What this trial is testing

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Who this might be right for
Central Nervous System NeoplasmsGlioblastomaGliosarcoma, Adult+20 more
Jazz Pharmaceuticals 102
Post-approval studies (Phase 4)Study completedNCT06625047
What this trial is testing

Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy

Who this might be right for
Astrocytoma, IDH-MutantGlioblastomaGlioma+1 more
Mayo Clinic 30
Early research (Phase 1)Study completedNCT00611728
What this trial is testing

Ph I SU011248 + Irinotecan in Treatment of Pts w MG

Who this might be right for
Glioblastoma
Duke University 25
Early research (Phase 1)Study completedNCT00326664
What this trial is testing

AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System Germ Cell TumorChildhood Cerebral Anaplastic Astrocytoma+18 more
National Cancer Institute (NCI) 55
Early research (Phase 1)Study completedNCT00080054
What this trial is testing

Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas

Who this might be right for
GliomaGlioblastomaAstrocytoma+2 more
Pharmacyclics LLC. 24
Early research (Phase 1)Ended earlyNCT00112619
What this trial is testing

Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsCarcinoma of Unknown PrimaryLeukemia+2 more
Pediatric Brain Tumor Consortium 19
Not applicableUnknownNCT06241391
What this trial is testing

Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas

Who this might be right for
GliomaAstrocytomaAnaplastic Astrocytoma+2 more
All India Institute of Medical Sciences, Bhubaneswar 35
Testing effectiveness (Phase 2)Ended earlyNCT01110876
What this trial is testing

Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Brain CancerGlioblastoma Multiforme
M.D. Anderson Cancer Center 21
Not applicableUnknownNCT02119338
What this trial is testing

5-ALA in Recurrent Glioma

Who this might be right for
Glioma
St. Joseph's Hospital and Medical Center, Phoenix 60
Testing effectiveness (Phase 2)Ended earlyNCT01478321
What this trial is testing

Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+2 more
Northwestern University 54
Testing effectiveness (Phase 2)Study completedNCT00003304
What this trial is testing

Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 29
Early research (Phase 1)Study completedNCT00002572
What this trial is testing

Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
University of Colorado, Denver 10
Not applicableLooking for participantsNCT05190172
What this trial is testing

PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas

Who this might be right for
OligodendrogliomaOligodendroglioma, AnaplasticDiffuse Astrocytoma, IDH-Mutant
Oslo University Hospital 225
Testing effectiveness (Phase 2)Study completedNCT00003465
What this trial is testing

Temozolomide in Treating Patients With Anaplastic Oligodendroglioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 60
Early research (Phase 1)Study completedNCT00017264
What this trial is testing

Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Not applicableUnknownNCT05624736
What this trial is testing

Hierarchical Diagnosis for Adult Diffuse Glioma Based on Deep Learning

Who this might be right for
AstrocytomaGlioblastoma MultiformeOligodendroglioma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 500
Testing effectiveness (Phase 2)Study completedNCT00079092
What this trial is testing

Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Wake Forest University Health Sciences 18
Not applicableLooking for participantsNCT07608003
What this trial is testing

Multicenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:

Who this might be right for
Gliomas Harboring IDH1 and/or IDH2 MutationsGlioma Glioblastoma MultiformeGlioma of Brainstem+3 more
Xiangya Hospital of Central South University 500
Next Page